Abstract:Context: Fetuin-A, a liver-derived glycoprotein that impairs insulin signaling, is associated with nonalcoholic fatty liver disease (NAFLD), diabetes, and the risk of cardiovascular diseases. Both prediabetes and NAFLD are associated with increased cardiovascular risk, and their concurrence significantly impairs hepatic and adipose tissue insulin sensitivity. Objective: Our objective was to investigate the relationship between serum fetuin-A levels and prediabetes in subjects with or without NAFLD. Design: This was a cross-sectional case-control study. Patients: A total of 510 age- and sex-matched subjects with normal glucose tolerance (NGT), impaired fasting glucose (IFG), and impaired glucose tolerance (IGT) with or without NAFLD were recruited. Each subject was assessed by abdominal ultrasound to diagnose NAFLD. Main outcome measures: Serum fetuin-A concentrations were compared between groups. The association with clinico-metabolic parameters was examined. Results: The presence of NAFLD significantly increases fetuin-A levels in subjects with NGT and prediabetes. As compared with NGT, IGT, but not IFG, significantly increases fetuin-A levels in subjects with or without NAFLD. Serum fetuin-A concentrations were positively related to postload 2-h glucose, body mass index, triglyceride, and homeostasis model assessment of insulin resistance but negatively associated with age, high-density lipoprotein cholesterol, and adiponectin. In multiple regression analysis, age, IGT vs. NGT, and IGT with NAFLD vs. NGT were independently associated with fetuin-A levels after adjustment for cardiovascular risk factors and adiponectin. Conclusions: IGT with or without NAFLD was independently associated with fetuin-A levels after adjustment for cardiometabolic risk factors. The elevated fetuin-A levels could have a clinical implication in the increased cardiovascular risk and insulin resistance associated with NAFLD and IGT.

Serum Fetuin B Level Increased in Subjects of Nonalcoholic Fatty Liver Disease: a Case-Control Study.

Serum Fetuin A Level is Associated with Nonalcoholic Fatty Liver Disease in Chinese Population

Serum betatrophin level increased in subjects with nonalcoholic fatty liver disease

Association Between Serum Afamin Levels with Nonalcoholic Associated Fatty Liver Disease

Association Between Serum Free Fatty Acid Levels and Nonalcoholic Fatty Liver Disease: a Cross-Sectional Study

Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose

Fetuin B Aggravates Liver X Receptor-Mediated Hepatic Steatosis Through AMPK in HepG2 Cells and Mice.

Circulating Igfbp-2 Levels Are Inversely Associated With The Incidence Of Nonalcoholic Fatty Liver Disease: A Cohort Study

Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes

Serum vitamin D levels are inversely related with non-alcoholic fatty liver disease independent of visceral obesity in Chinese postmenopausal women.

Relationship of Serum Uric Acid Level with Non-Alcoholic Fatty Liver Disease and Its Inflammation Progression in Non-Obese Adults.

Association between serum α-L-fucosidase and non-alcoholic fatty liver disease: Cross-sectional study.

Serum Proteomic Analysis Revealed Diagnostic Value of Hemoglobin for Nonalcoholic Fatty Liver Disease

Increased serum levels of fetuin B in patients with coronary artery disease

Serum Fetuin-a is Correlated with Metabolic Syndrome in Middle-Aged and Elderly Chinese.

Serum periostin is a potential biomarker for non-alcoholic fatty liver disease: a case–control study

Serum Apob Levels Independently Predict the Development of Non-Alcoholic Fatty Liver Disease: A 7-Year Prospective Study

Serum Level of Fetuin B is Associated with Osteoporosis: a 4-Year Prospective Study in China

Serum Fetuin-A Associates With Type 2 Diabetes And Insulin Resistance In Chinese Adults

Serum Sialic Acid Level Is Significantly Associated with Nonalcoholic Fatty Liver Disease in a Nonobese Chinese Population: A Cross-Sectional Study

Serum folate associated with nonalcoholic fatty liver disease and advanced hepatic fibrosis